Tumor Biology

, Volume 35, Issue 5, pp 4913–4920 | Cite as

Lack of association between vitamin D receptor gene ApaI, BsmI, and TaqI polymorphisms and primary biliary cirrhosis risk: a meta-analysis

  • Cuiju Mo
  • Yu Lu
  • Yan Deng
  • Jian Wang
  • Li Xie
  • Taijie Li
  • Yu He
  • Xue Qin
  • Shan Li
Research Article


Previous studies have reported the association between vitamin D receptor (VDR) polymorphisms and the risk of primary biliary cirrhosis (PBC), although these results remain controversial. The aim of this meta-analysis was to evaluate the association of three polymorphisms in VDR with PBC risk. The relevant studies were identified through an electronic database search carried out in September 2013. The crude odds ratio (OR) and 95 % confidence interval (CI) were calculated to assess the association between VDR polymorphisms and PBC risk. Six eligible studies which met our selection criteria were included. Overall, the ApaI, BsmI, and TaqI polymorphisms in the VDR gene were not associated with PBC risk (ApaI A vs a OR = 1.132, 95 % CI = 0.870–1.472, p = 0.355; BsmI B vs b OR = 1.148, 95 % CI = 0.697–1.891, p = 0.589; TaqI t vs T OR = 1.1432, 95 % CI = 0.709–1.841, p = 0.584). Furthermore, in subgroup analysis by ethnicity for the ApaI, BsmI, and TaqI polymorphisms, there were no significant results in either Caucasians or Asians under the allele contrast and recessive and dominant models. This meta-analysis indicated that VDR polymorphisms were not a risk factor for PBC. Larger and more carefully designed studies are needed to verify our results.


Vitamin D receptor Primary biliary cirrhosis Meta-analysis 


Conflicts of interest



  1. 1.
    Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet. 2003;362:53–61.CrossRefPubMedGoogle Scholar
  3. 3.
    Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol. 1999;30:402–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Chen RR, Han ZY, Li JG, Shi YQ, Zhou XM, Wang JB, et al. Cytotoxic t-lymphocyte antigen 4 gene +49a/g polymorphism significantly associated with susceptibility to primary biliary cirrhosis: a meta-analysis. J Dig Dis. 2011;12:428–35.CrossRefPubMedGoogle Scholar
  5. 5.
    Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology. 2008;48:1906–12.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Jones DE, Watt FE, Grove J, Newton JL, Daly AK, Gregory WL, et al. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. J Hepatol. 1999;30:232–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev. 2011;10:733–43.CrossRefPubMedGoogle Scholar
  8. 8.
    Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves’ disease. Thyroid. 2000;10:375–80.CrossRefPubMedGoogle Scholar
  9. 9.
    Ban Y, Taniyama M, Yanagawa T, Yamada S, Maruyama T, Kasuga A. Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet. 2001;2:7.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K, et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci. 1999;166:47–52.CrossRefPubMedGoogle Scholar
  11. 11.
    Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord. 2001;2:203–16.CrossRefPubMedGoogle Scholar
  12. 12.
    Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997;12:915–21.CrossRefPubMedGoogle Scholar
  13. 13.
    Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S, et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol. 1997;11:1165–79.CrossRefPubMedGoogle Scholar
  14. 14.
    Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177:145–59.CrossRefPubMedGoogle Scholar
  15. 15.
    Harada K, Nakanuma Y. Biliary innate immunity and cholangiopathy. Hepatol Res. 2007;37 Suppl 3:S430–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Pares A, Guanabens N, Rodes J. Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 2005;17:311–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, et al. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol. 2005;20:249–55.CrossRefPubMedGoogle Scholar
  18. 18.
    Halmos B, Szalay F, Cserniczky T, Nemesanszky E, Lakatos P, Barlage S, et al. Association of primary biliary cirrhosis with vitamin D receptor bsmI genotype polymorphism in a Hungarian population. Dig Dis Sci. 2000;45:1091–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Kempinska-Podhorecka A, Wunsch E, Jarowicz T, Raszeja-Wyszomirska J, Loniewska B, Kaczmarczyk M, et al. Vitamin D receptor polymorphisms predispose to primary biliary cirrhosis and severity of the disease in Polish population. Gastroenterol Res Pract. 2012;2012:408723.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Lakatos LP, Bajnok E, Hegedus D, Toth T, Lakatos P, Szalay F. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 2002;14:733–40.CrossRefPubMedGoogle Scholar
  21. 21.
    Tanaka A, Nezu S, Uegaki S, Kikuchi K, Shibuya A, Miyakawa H, et al. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol. 2009;50:1202–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology. 2002;35:126–31.CrossRefPubMedGoogle Scholar
  23. 23.
    Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2005;24:1291–306.CrossRefPubMedGoogle Scholar
  24. 24.
    Adorini L. Vitamin D receptor polymorphisms in primary biliary cirrhosis: a functional connection? J Hepatol. 2009;50:1071–3.CrossRefPubMedGoogle Scholar
  25. 25.
    Resnick RH, Chopra S. Vitamin D receptor gene analysis in primary biliary cirrhosis. Gastroenterology. 2000;119:1805.CrossRefPubMedGoogle Scholar
  26. 26.
    Fan LY, Zhong RQ, Tu XQ, Zhu Y, Gong CL, Zhou L. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune liver diseases on Chinese. Zhonghua Yi Xue Za Zhi. 2003;83:1852–5.PubMedGoogle Scholar
  27. 27.
    Vleggaar FP, van Buuren HR, Wolfhagen FH, Schalm SW, Pols HA. Prevention and treatment of osteoporosis in primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 1999;11:617–21.CrossRefPubMedGoogle Scholar
  28. 28.
    Xu J, Turner A, Little J, Bleecker ER, Meyers DA. Positive results in association studies are associated with departure from Hardy–Weinberg equilibrium: hint for genotyping error? Hum Genet. 2002;111:573–4.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Department of Clinical LaboratoryFirst Affiliated Hospital of Guangxi Medical UniversityNanningChina

Personalised recommendations